Fuso Pharmaceutical Industries (TSE:4538) Beta: 0.0472 (As of Jun. 25, 2026)


TSE:4538 Fuso Pharmaceutical Industries Ltd TSE:4538
47 GF Score
Price 円2,066.00
GF Value 円2,539.87
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Fuso Pharmaceutical Industries Beta?

Fuso Pharmaceutical Industries TSE:4538 +0.54% 47 Beta is 0.0472 as of Jun. 25, 2026. GuruFocus rates TSE:4538 with a GF Score™ of 47/100 and a GF Value™ of 円2,539.87 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Fuso Pharmaceutical Industries's Beta is 0.0472.


Fuso Pharmaceutical Industries  (TSE:4538) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Fuso Pharmaceutical Industries Beta Related Terms


Fuso Pharmaceutical Industries Beta Historical Data

* Premium members only.

The historical data trend for Fuso Pharmaceutical Industries's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuso Pharmaceutical Industries Beta Chart

Fuso Pharmaceutical Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.64 0.82 0.56 0.38 0.17

Fuso Pharmaceutical Industries Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.38 0.25 0.20 0.00

TSE:4538 vs ZTS: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Fuso Pharmaceutical Industries's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuso Pharmaceutical Industries Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fuso Pharmaceutical Industries's Beta distribution charts can be found below:

* The bar in red indicates where Fuso Pharmaceutical Industries's Beta falls into.


TSE:4538
47GF Score
Fuso Pharmaceutical Industries Ltd TSE:4538
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fuso Pharmaceutical Industries Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.0472 mean?
Fuso Pharmaceutical Industries (TSE:4538) has a Beta of 0.0472 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Fuso Pharmaceutical Industries and its competitors.
Is Fuso Pharmaceutical Industries' Beta too high?
Fuso Pharmaceutical Industries' current Beta is 0.0472. Overall, Fuso Pharmaceutical Industries has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fuso Pharmaceutical Industries' Beta compare to ZTS?
Fuso Pharmaceutical Industries' Beta of 0.0472 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Fuso Pharmaceutical Industries and its competitors. Fuso Pharmaceutical Industries's current Beta is 0.0472. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuso Pharmaceutical Industries stock overvalued right now?
Based on GuruFocus' analysis, Fuso Pharmaceutical Industries (TSE:4538) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,539.87, compared to a current price of 円2,066.00 — trading 18.7% below its estimated fair value. The current Beta is 0.0472. Fuso Pharmaceutical Industries' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Fuso Pharmaceutical Industries (TSE:4538), the current Beta is 0.0472 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fuso Pharmaceutical Industries (TSE:4538) Overvalued in 2026?

Based on GuruFocus' analysis, Fuso Pharmaceutical Industries stock appears to be undervalued. The current stock price of 円2,066.00 is trading 18.7% below its estimated GF Value™ of 円2,539.87. GuruFocus considers Fuso Pharmaceutical Industries to be Modestly Undervalued.

Key valuation signals for TSE:4538:

  • Beta: 0.0472
  • GF Value™: 円2,539.87 vs. price of 円2,066.00 (18.7% below fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the TSE:4538 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fuso Pharmaceutical Industries Business Description

Address No. 10, No. 7-chome Doshomachi, Chuo-ku, OsaKa, JPN, 541-0045
Fuso Pharmaceutical Industries Ltd. is engaged in the manufacture and sale of pharmaceuticals and medical equipment. The company's main products are transfusion fluid and artificial kidney dialysis fluid. Company also includes real estate segment.
47GF Score

Get the complete analysis for TSE:4538

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,066.00
Price
円2,539.87
GF Value